With a market capitalization (market cap) of $653.35B — a measure of how much the company is worth — Johnson & Johnson is the 21st most valuable company in Healthcare as of August 19, 2026. Shares trade at $271.11, up +3.33% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Visit websiteAs of August 19, 2026, Johnson & Johnson (JNJ) is worth $653.35B — this is its market capitalization, the total value of all its outstanding shares.
Johnson & Johnson’s market cap is $653.35B, which ranks it #21 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Johnson & Johnson (JNJ) shares trade at $271.11, up 3.33% on the day, as of August 19, 2026.
Johnson & Johnson trades at a price-to-earnings (P/E) ratio of 24.6, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025